Bolognese J - Search Results

1

Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study Group.

Murphy MG, Bach MA, Plotkin D, Bolognese J, Ng J, Krupa D, Cerchio K, Gertz BJ. Murphy MG, et al. Among authors: bolognese j. J Bone Miner Res. 1999 Jul;14(7):1182-8. doi: 10.1359/jbmr.1999.14.7.1182. J Bone Miner Res. 1999. PMID: 10404019 Free article. Clinical Trial.

2

Effect of specific COX-2 inhibition in osteoarthritis of the knee: a 6 week double blind, placebo controlled pilot study of rofecoxib. Rofecoxib Osteoarthritis Pilot Study Group.

Ehrich EW, Schnitzer TJ, McIlwain H, Levy R, Wolfe F, Weisman M, Zeng Q, Morrison B, Bolognese J, Seidenberg B, Gertz BJ. Ehrich EW, et al. Among authors: bolognese j. J Rheumatol. 1999 Nov;26(11):2438-47. J Rheumatol. 1999. PMID: 10555907 Clinical Trial.

3

Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors.

Detora LM, Krupa D, Bolognese J, Sperling RS, Ehrich EW. Detora LM, et al. Among authors: bolognese j. J Rheumatol. 2001 Nov;28(11):2494-503. J Rheumatol. 2001. PMID: 11708424

4

A comparison of adverse renovascular experiences among osteoarthritis patients treated with rofecoxib and comparator non-selective non-steroidal anti-inflammatory agents.

Gertz BJ, Krupa D, Bolognese JA, Sperling RS, Reicin A. Gertz BJ, et al. Among authors: bolognese ja. Curr Med Res Opin. 2002;18(2):82-91. doi: 10.1185/030079902125000354. Curr Med Res Opin. 2002. PMID: 12017215

5

Use of gastroprotective agents and discontinuations due to dyspepsia with the selective cyclooxygenase-2 inhibitor etoricoxib compared with non-selective NSAIDs.

Watson DJ, Bolognese JA, Yu C, Krupa D, Curtis S. Watson DJ, et al. Among authors: bolognese ja. Curr Med Res Opin. 2004 Dec;20(12):1899-908. doi: 10.1185/030079904X12681. Curr Med Res Opin. 2004. PMID: 15701208

6

A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis. Rofecoxib/Ibuprofen Comparator Study Group.

Day R, Morrison B, Luza A, Castaneda O, Strusberg A, Nahir M, Helgetveit KB, Kress B, Daniels B, Bolognese J, Krupa D, Seidenberg B, Ehrich E. Day R, et al. Among authors: bolognese j. Arch Intern Med. 2000 Jun 26;160(12):1781-7. doi: 10.1001/archinte.160.12.1781. Arch Intern Med. 2000. PMID: 10871971 Clinical Trial.

7

Effect of morphine and pregabalin compared with diphenhydramine hydrochloride and placebo on hyperalgesia and allodynia induced by intradermal capsaicin in healthy male subjects.

Wang H, Bolognese J, Calder N, Baxendale J, Kehler A, Cummings C, Connell J, Herman G. Wang H, et al. Among authors: bolognese j. J Pain. 2008 Dec;9(12):1088-95. doi: 10.1016/j.jpain.2008.05.013. J Pain. 2008. PMID: 19038771 Free article. Clinical Trial.

8

Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man.

Copinschi G, Leproult R, Van Onderbergen A, Caufriez A, Cole KY, Schilling LM, Mendel CM, De Lepeleire I, Bolognese JA, Van Cauter E. Copinschi G, et al. Among authors: bolognese ja. Neuroendocrinology. 1997 Oct;66(4):278-86. doi: 10.1159/000127249. Neuroendocrinology. 1997. PMID: 9349662 Clinical Trial.

9

Lisinopril: dose-peak effect relationship in essential hypertension.

Cirillo VJ, Gomez HJ, Salonen J, Salonen R, Rissanen V, Bolognese JA, Nyberg R, Kristianson K. Cirillo VJ, et al. Among authors: bolognese ja. Br J Clin Pharmacol. 1988 May;25(5):533-8. doi: 10.1111/j.1365-2125.1988.tb03342.x. Br J Clin Pharmacol. 1988. PMID: 2841960 Free PMC article. Clinical Trial.

10

Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men.

Copinschi G, Van Onderbergen A, L'Hermite-Balériaux M, Mendel CM, Caufriez A, Leproult R, Bolognese JA, De Smet M, Thorner MO, Van Cauter E. Copinschi G, et al. Among authors: bolognese ja. J Clin Endocrinol Metab. 1996 Aug;81(8):2776-82. doi: 10.1210/jcem.81.8.8768828. J Clin Endocrinol Metab. 1996. PMID: 8768828 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters